Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Vallvé JC, Ferré R, Heras M, Rodríguez-Calvo R, Guaita-Esteruelas S, Martínez-Micaelo N, Plana N, Masana L.

J Clin Med. 2019 Oct 26;8(11). pii: E1793. doi: 10.3390/jcm8111793.

2.

Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c.

Parra S, Heras M, Herrero P, Amigó N, Garcés E, Girona J, Correig X, Canela N, Castro A.

Rheumatology (Oxford). 2019 Aug 23. pii: kez293. doi: 10.1093/rheumatology/kez293. [Epub ahead of print]

PMID:
31504936
3.

HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk.

Girona J, Amigó N, Ibarretxe D, Plana N, Rodríguez-Borjabad C, Heras M, Ferré R, Gil M, Correig X, Masana L.

Int J Mol Sci. 2019 Jun 27;20(13). pii: E3151. doi: 10.3390/ijms20133151.

4.

Plasma glucose, triglycerides, VLDL, leptin and resistin levels as potential biomarkers for myocardial fat in mice.

Rodríguez-Calvo R, Samino S, Guaita-Esteruelas S, Martínez-Micaelo N, Heras M, Girona J, Yanes O, Correig X, Masana L.

Clin Investig Arterioscler. 2019 Jun 17. pii: S0214-9168(19)30064-6. doi: 10.1016/j.arteri.2019.05.001. [Epub ahead of print] English, Spanish.

PMID:
31221535
5.

Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.

Rodríguez-Calvo R, Girona J, Rodríguez M, Samino S, Barroso E, de Gonzalo-Calvo D, Guaita-Esteruelas S, Heras M, van der Meer RW, Lamb HJ, Yanes O, Correig X, Llorente-Cortés V, Vázquez-Carrera M, Masana L.

Metabolism. 2019 Jul;96:12-21. doi: 10.1016/j.metabol.2019.04.007. Epub 2019 Apr 15.

PMID:
30999003
6.

Palmitate decreases migration and proliferation and increases oxidative stress and inflammation in smooth muscle cells: role of the Nrf2 signaling pathway.

Girona J, Rosales R, Saavedra P, Masana L, Vallvé JC.

Am J Physiol Cell Physiol. 2019 Jun 1;316(6):C888-C897. doi: 10.1152/ajpcell.00293.2018. Epub 2019 Mar 13.

PMID:
30865473
7.

FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.

Bosquet A, Girona J, Guaita-Esteruelas S, Heras M, Saavedra-García P, Martínez-Micaelo N, Masana L, Rodríguez-Calvo R.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jun;1863(6):604-613. doi: 10.1016/j.bbalip.2018.03.004. Epub 2018 Mar 15.

PMID:
29550588
8.

Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.

Rodríguez-Borjabad C, Ibarretxe D, Girona J, Ferré R, Feliu A, Amigó N, Guijarro E, Masana L, Plana N; DECOPIN Group.

Atherosclerosis. 2018 Mar;270:117-122. doi: 10.1016/j.atherosclerosis.2018.01.040. Epub 2018 Jan 31.

PMID:
29407879
9.

Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels-The zero-LDL hypothesis.

Masana L, Girona J, Ibarretxe D, Rodríguez-Calvo R, Rosales R, Vallvé JC, Rodríguez-Borjabad C, Guardiola M, Rodríguez M, Guaita-Esteruelas S, Oliva I, Martínez-Micaelo N, Heras M, Ferré R, Ribalta J, Plana N.

J Clin Lipidol. 2018 Mar - Apr;12(2):292-299.e3. doi: 10.1016/j.jacl.2017.12.018. Epub 2018 Jan 8. Review.

PMID:
29398429
10.

Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Heras M, Amigo N, Feliu A, Masana L, Plana N; DECOPIN Group.

J Clin Lipidol. 2018 Jan - Feb;12(1):211-218. doi: 10.1016/j.jacl.2017.10.003. Epub 2017 Oct 12.

PMID:
29102496
11.

Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.

Guaita-Esteruelas S, Saavedra-García P, Bosquet A, Borràs J, Girona J, Amiliano K, Rodríguez-Balada M, Heras M, Masana L, Gumà J.

Oncologist. 2017 Nov;22(11):1309-1315. doi: 10.1634/theoncologist.2016-0483. Epub 2017 Jul 12.

12.

Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease.

Rodríguez-Calvo R, Girona J, Alegret JM, Bosquet A, Ibarretxe D, Masana L.

J Endocrinol. 2017 Jun;233(3):R173-R184. doi: 10.1530/JOE-17-0031. Epub 2017 Apr 18. Review.

PMID:
28420707
13.

Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases.

Girona J, Ibarretxe D, Plana N, Guaita-Esteruelas S, Amigo N, Heras M, Masana L.

Cardiovasc Diabetol. 2016 Aug 4;15(1):107. doi: 10.1186/s12933-016-0428-z.

14.

[Long-term effects of continuous positive airway pressure treatment on subclinical atherosclerosis in obstructive sleep apnoea syndrome].

Català R, Ferré R, Cabré A, Girona J, Porto M, Texidó A, Masana L.

Med Clin (Barc). 2016 Jul 1;147(1):1-6. doi: 10.1016/j.medcli.2016.03.032. Spanish.

PMID:
27210810
15.

Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells.

Bosquet A, Guaita-Esteruelas S, Saavedra P, Rodríguez-Calvo R, Heras M, Girona J, Masana L.

Atherosclerosis. 2016 Jun;249:191-9. doi: 10.1016/j.atherosclerosis.2016.04.012. Epub 2016 Apr 14.

PMID:
27155388
16.

Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins.

Guaita-Esteruelas S, Bosquet A, Saavedra P, Gumà J, Girona J, Lam EW, Amillano K, Borràs J, Masana L.

Mol Carcinog. 2017 Jan;56(1):208-217. doi: 10.1002/mc.22485. Epub 2016 Apr 6.

17.

Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders.

Ibarretxe D, Girona J, Amigó N, Plana N, Ferré R, Guaita S, Mallol R, Heras M, Masana L.

J Clin Lipidol. 2016 Mar-Apr;10(2):330-8.e2. doi: 10.1016/j.jacl.2015.12.012. Epub 2015 Dec 22.

PMID:
27055964
18.

Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders.

Ibarretxe D, Girona J, Plana N, Cabré A, Ferré R, Amigó N, Guaita S, Mallol R, Heras M, Masana L.

Clin Investig Arterioscler. 2016 Mar-Apr;28(2):71-8. doi: 10.1016/j.arteri.2015.11.001. Epub 2015 Dec 29.

PMID:
26743379
19.

Correction: FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration through a MAPK-Dependent Pathway.

Girona J, Rosales R, Plana N, Saavedra P, Masana L, Vallvé JC.

PLoS One. 2016 Jan 5;11(1):e0146632. doi: 10.1371/journal.pone.0146632. eCollection 2016. No abstract available.

20.

Body mass index correlates with atherogenic lipoprotein profile even in nonobese, normoglycemic, and normolipidemic healthy men.

Guardiola M, Solà R, Vallvé JC, Girona J, Godàs G, Heras M, Gonzàlez M, Rock E, Winklhoffer-Roob BM, Masana L, Ribalta J.

J Clin Lipidol. 2015 Nov-Dec;9(6):824-831.e1. doi: 10.1016/j.jacl.2015.08.001. Epub 2015 Aug 7.

PMID:
26687704

Supplemental Content

Loading ...
Support Center